telmisartan has been researched along with Acute Kidney Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kassie, GM; Kerr, M; Moffat, A; Pratt, N; Roughead, EE | 1 |
| Hosoda, A; Kohno, T; Masamichi, S; Matsumoto, Y; Toriyama, Y; Tsuji, T; Yoshida, Y | 1 |
| De Bernardo, G; Marchetto, L; Sordino, D; Trevisanuto, D | 1 |
| Akcilar, R; Aras, B; Bayat, Z; Kocak, C; Kocak, FE; Metineren, MH; Simsek, H; Yucel, M | 1 |
| Alhusseini, NF; Ali, SI; Atteia, HH; Hasan, RA; Idris, RA | 1 |
| Bhalodia, Y; Jivani, N; Sheth, N; Vaghasiya, J | 1 |
6 other study(ies) available for telmisartan and Acute Kidney Failure
| Article | Year |
|---|---|
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary Care.
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Amlodipine; Amphotericin B; Australia; Case-Control Studies; Ciprofloxacin; Diclofenac; Furosemide; Humans; Ibuprofen; Metformin; Naproxen; Omeprazole; Primary Health Care; Ramipril; Simvastatin; Spironolactone; Sulfamethoxazole; Telmisartan; Trimethoprim; Valacyclovir; Zoledronic Acid | 2022 |
Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Topics: Acute Kidney Injury; Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Blood Pressure; Blood Urea Nitrogen; Calcium Channel Blockers; Cisplatin; Creatinine; Disease Models, Animal; Drug Synergism; Fibrosis; Humans; Injections, Intraperitoneal; Kidney; Male; Mice; Neoplasms; Severity of Illness Index; Telmisartan | 2020 |
Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.
Topics: Acute Kidney Injury; Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Female; Humans; Hypertension; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Telmisartan | 2015 |
Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Antioxidants; Apoptosis; Arginine; Benzimidazoles; Benzoates; Captopril; Creatine; Endothelin-1; Gene Expression Regulation; Glutathione Peroxidase; Ischemia; Kidney; Lipocalin-2; Lipocalins; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oleanolic Acid; Proto-Oncogene Proteins; Rats; Rats, Wistar; Reperfusion Injury; Sulfhydryl Compounds; Superoxide Dismutase; Telmisartan; Urea | 2016 |
Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats.
Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Garlic; Kidney; Obesity; Rats; Reperfusion Injury; Telmisartan | 2016 |
Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Drug Therapy, Combination; Fenofibrate; Homocysteine; Hypolipidemic Agents; Kidney; Kidney Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Telmisartan | 2010 |